News Focus
News Focus
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: n4807g post# 4182

Tuesday, 07/18/2017 11:59:06 AM

Tuesday, July 18, 2017 11:59:06 AM

Post# of 7747
I've been digging Albumin binding mechanism. The nano particle deliver mechanism isn't unheard off. There have been many drugs successfully employed such delivery method. I'd say there are definitely interested parties especially a drug that FDA agrees to a path way and granting rolling NDA, approval chances are good. Plus Aldoxrubicin have been listed as new STS treatment method but information is not up to date with current development. That much is well known public information. I don't think many people will disagree on that.

So what's in store for Cytrx is all on management.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today